|
|||||
|
|
Acute myeloid leukemia: Treatment and research outlook for 2021 and the MD Anderson approach |
|
| Authors: | Hagop M. Kantarjian MD Tapan M. Kadia MD Courtney D. DiNardo MD Mary Alma Welch MMSC Farhad Ravandi MD |
| Affiliation: | Department of Leukemia, MD Anderson Cancer Center, Houston, Texas |
| Abstract: | |
| Keywords: | acute myelogenous leukemia new drugs progress research therapy |